Neonatal group B streptococcal disease: Incidence, presentation, and mortality

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 21, Issue 1, 2008, Pages 53-57

  Hamada, Sudqi ^a,b   Vearncombe, Mary ^b,c   McGeer, Allison ^a,b   Shah, Prakesh S ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Epidemiologic features; Infant; Newborn; Streptococcal infections

Indexed keywords

ARTICLE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEMALE; GROUP B STREPTOCOCCUS DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN DISEASE; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SHOCK; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

ADULT; BACTEREMIA; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; MENINGITIS; ONTARIO; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; THROMBOCYTOPENIA;

EID: 37849006469     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701787474     Document Type: Article

References (27)

1. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: A study of 33 infants. J Pediatr 1973;82:724-729.
2. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-718.
3. McCracken GH Jr. Group B streptococci: The new challenge in neonatal infections. J Pediatr 1973;82:703-706.
4. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Recomm Rep 1996;45:1-24.
5. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
6. Diminishing racial disparities in early-onset neonatal group B streptococcal disease - United States, 2000-2003. MMWR Morb Mortal Wkly Rep 2004;53:502-505.
7. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
8. Early-onset and late-onset neonatal group B streptococcal disease-United States, 1996-2004. MMWR Morb Mortal Wkly Rep 2005;54:1205-1208.
9. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell La, Cafferkey M, Verlander NQ, Nicoll A, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-294.
10. Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, Russell AB. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003;361:1953-1954.
11. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994;16:374-402.
12. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992;41:25-32.
13. Schuchat A. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 1998;11:497-513.
14. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: A 6-year prospective study. J Pediatr 1987;110:31-36.
15. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-1246.
16. Adair CE, Kowalsky L, Quon H, Ma D, Stoffman J, McGeer A, Robertson S, Mucenski M, Davies HD. Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study. CMAJ 2003;169:198-203.
17. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981;68:544-549.
18. Benitz WE, Gould JB, DruzinML. Risk factors for early-onset group B streptococcal sepsis: Estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77.
19. Faxelius G, Bremme K, Kvist-Christensen K, Christensen P, Ringertz S. Neonatal septicemia due to group B streptococci - perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988;16:423-430.
20. Lieu TA, Mohle-Boetani JC, Ray GT, Ackerson LM, Walton DL. Neonatal group B streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group. Obstet Gynecol 1998;92:21-27.
21. Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus: Maternal and nosocomial sources for infant acquisitions. J Pediatr 1979;95:431-436.
22. Trager JD, Martin JM, Barbadora K, Green M, Wald ER. Probable community acquisition of group B Streptococcus in an infant with late-onset disease: Demonstration using field inversion gel electrophoresis. Arch Pediatr Adolesc Med 1996;150:766-768.
23. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-250.
24. Moses LM, Heath PT, Wilkinson AR, Jeffery HE, Isaacs D. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed 1998;79:F148-F149.
25. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-756.
26. Payne NR, Burke BA, Day DL, Christenson PD, Thompson TR, Ferrieri P. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J 1988;7:836-847.
27. Lin FY, Weisman LE, Troendle J, Adams K. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis 2003;188:267-271.